These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 34966784)
1. The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis. Fuji H; Miller G; Nishio T; Koyama Y; Lam K; Zhang V; Loomba R; Brenner D; Kisseleva T Front Mol Biosci; 2021; 8():790032. PubMed ID: 34966784 [TBL] [Abstract][Full Text] [Related]
2. The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury. Nishio T; Koyama Y; Fuji H; Ishizuka K; Iwaisako K; Taura K; Hatano E; Brenner DA; Kisseleva T Biology (Basel); 2022 Oct; 11(11):. PubMed ID: 36358290 [TBL] [Abstract][Full Text] [Related]
3. Origin of myofibroblasts in the fibrotic liver in mice. Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909 [TBL] [Abstract][Full Text] [Related]
4. Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. Koyama Y; Wang P; Liang S; Iwaisako K; Liu X; Xu J; Zhang M; Sun M; Cong M; Karin D; Taura K; Benner C; Heinz S; Bera T; Brenner DA; Kisseleva T J Clin Invest; 2017 Apr; 127(4):1254-1270. PubMed ID: 28287406 [TBL] [Abstract][Full Text] [Related]
5. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice. Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy-based targeting of MSLN Nishio T; Koyama Y; Liu X; Rosenthal SB; Yamamoto G; Fuji H; Baglieri J; Li N; Brenner LN; Iwaisako K; Taura K; Hagood JS; LaRusso NF; Bera TK; Pastan I; Brenner DA; Kisseleva T Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34253615 [TBL] [Abstract][Full Text] [Related]
7. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis. Karin D; Koyama Y; Brenner D; Kisseleva T Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095 [TBL] [Abstract][Full Text] [Related]
8. Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants. Fausther M; G Lavoie E; Dranoff JA PLoS One; 2017; 12(9):e0184499. PubMed ID: 28898276 [TBL] [Abstract][Full Text] [Related]
9. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. Lua I; Li Y; Zagory JA; Wang KS; French SW; Sévigny J; Asahina K J Hepatol; 2016 May; 64(5):1137-1146. PubMed ID: 26806818 [TBL] [Abstract][Full Text] [Related]
10. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Yang W; He H; Wang T; Su N; Zhang F; Jiang K; Zhu J; Zhang C; Niu K; Wang L; Yuan X; Liu N; Li L; Wei W; Hu J Hepatology; 2021 Nov; 74(5):2774-2790. PubMed ID: 34089528 [TBL] [Abstract][Full Text] [Related]
11. The Origin and Fate of Liver Myofibroblasts. Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012 [TBL] [Abstract][Full Text] [Related]
12. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Xu J; Liu X; Koyama Y; Wang P; Lan T; Kim IG; Kim IH; Ma HY; Kisseleva T Front Pharmacol; 2014; 5():167. PubMed ID: 25100997 [TBL] [Abstract][Full Text] [Related]
13. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma. Yavuz BG; Pestana RC; Abugabal YI; Krishnan S; Chen J; Hassan MM; Wolff RA; Rashid A; Amin HM; Kaseb AO Oncotarget; 2020 Mar; 11(13):1186-1201. PubMed ID: 32284794 [TBL] [Abstract][Full Text] [Related]
14. Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic- and cholestatic-induced liver injury. Benitez R; Caro M; Andres-Leon E; O'Valle F; Delgado M Br J Pharmacol; 2022 May; 179(10):2275-2296. PubMed ID: 34821378 [TBL] [Abstract][Full Text] [Related]
15. Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis. Konishi T; Schuster RM; Lentsch AB Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G323-G331. PubMed ID: 30543462 [TBL] [Abstract][Full Text] [Related]
16. Human Hepatic Stellate Cells: Isolation and Characterization. Liu X; Brenner DA; Kisseleva T Methods Mol Biol; 2023; 2669():221-232. PubMed ID: 37247063 [TBL] [Abstract][Full Text] [Related]
17. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease. Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776 [TBL] [Abstract][Full Text] [Related]
18. Cooperation of liver cells in health and disease. Kmieć Z Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749 [TBL] [Abstract][Full Text] [Related]
19. Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury. Katsumata LW; Miyajima A; Itoh T Hepatol Commun; 2017 May; 1(3):198-214. PubMed ID: 29404454 [TBL] [Abstract][Full Text] [Related]
20. Portal tract fibrogenesis in the liver. Ramadori G; Saile B Lab Invest; 2004 Feb; 84(2):153-9. PubMed ID: 14688800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]